Numerous studies have demonstrated the benefit of an early invasive strategy in patients presenting with non-ST elevation acute coronary syndromes (ACS).
The recent literature is filled with trials of type II diabetes (DM) treatment and cardiovascular (CV) disease, with conflicting conclusions. While intuitively reasonable, not all trials of intensive glucose management in diabetes have been found to reduce CV events nor decrease CV mortality.
In this paper, Dorian et al attempt to validate a relatively simple symptom scoring system for use in patients with atrial fibrillation (AF). The proposed Canadian Cardiovascular Society Severity in Atrial Fibrillation (CCS-SAF) scale is based upon symptoms attributable to AF, the association between symptoms and documentation of AF or AF therapies, and the functional consequences of these symptoms on the patient's daily life.
After the JUPITER trial showed that individuals with LDL cholesterols < 130 mg/dL, but high sensitivity CRP > 2.0 benefited from statin therapy, there has been considerable interest in using biomarkers for individualizing treatment.
This paper describes the results of an epidemiologic survey of the results of in-hospital cardiopulmonary resuscitation (CPR) in U.S. hospitals. Ehlenbach et al analyzed the Medicare Provider Analysis and Review (MedPAR) hospital claims database for the years from 1992-2005 and identified Medicare beneficiaries for whom a claim for in-hospital CPR had been made.
Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions.
In this issue: Clopidogrel and proton pump inhibitors; adverse events with tamsulosin after cataract surgery; new guidelines for persistent pain in the elderly; and FDA Actions.
Numerous studies have demonstrated the benefit of an early invasive strategy in patients presenting with non-ST elevation acute coronary syndromes (ACS).
